Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Milrinone infusion
DRUG
2 trials
Sponsors
Zagazig University
, NICHD Neonatal Research Network
Conditions
Post-ligation Cardiac Syndrome
Pulmonary Hypertension Due to Left Heart Disease
Phase 3
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
Recruiting
NCT06679855
NICHD Neonatal Research Network
Post-ligation Cardiac Syndrome
Start: 2025-06-13
End: 2029-06-30
Target: 316
Updated: 2026-07-01
Phase 4
Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension
Recruiting
NCT04484675
Zagazig University
Pulmonary Hypertension Due to Left Heart Disease
Start: 2023-05-20
End: 2025-05-10
Target: 38
Updated: 2025-04-30
Related Papers
Evaluating the efficacy and safety of milrinone for prevention of post-patent ductus arteriosus closure syndrome (the MIDAS trial) in extremely preterm infants: a multicentre, double-masked, randomised, placebo-controlled trial
BMJ Open
2025-08-01